Predictive biomarkers of antiangiogenic therapy for advanced hepatocellular carcinoma: where are we?
about
Evaluation of antiangiogenic efficacy in advanced hepatocellular carcinoma: Biomarkers and functional imagingAndrogen receptor signaling in hepatocellular carcinoma and pancreatic cancersSorafenib Therapy for BCLC Stage B/C Hepatocellular Carcinoma; Clinical Outcome and Safety in Aged Patients: A Multicenter Study in JapanEarly Clinical Response after 2 Weeks of Sorafenib Therapy Predicts Outcomes and Anti-Tumor Response in Patients with Advanced Hepatocellular Carcinoma.Organic Cation Transporter 1 (OCT1) mRNA expression in hepatocellular carcinoma as a biomarker for sorafenib treatmentEfficacy of sorafenib in BRAF-mutated non-small-cell lung cancer (NSCLC) and no response in synchronous BRAF wild type-hepatocellular carcinoma: a case report.Activation of c-Jun predicts a poor response to sorafenib in hepatocellular carcinoma: Preliminary Clinical EvidenceSorafenib in advanced hepatocellular carcinoma: current status and future perspectives.Early onset of hypertension and serum electrolyte changes as potential predictive factors of activity in advanced HCC patients treated with sorafenib: results from a retrospective analysis of the HCC-AVR group.eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: final results of the ePHAS study.Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib.Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility.Biomarkers for the early diagnosis of bacterial infection and the surveillance of hepatocellular carcinoma in cirrhosis.Immune Checkpoint Blockade in Hepatocellular Carcinoma.Clinical features associated with radiological response to sorafenib in unresectable hepatocellular carcinoma: a large multicenter study in Japan.High plasma interleukin-6 levels associated with poor prognosis of patients with advanced hepatocellular carcinoma.GTSF1 gene may serve as a novel potential diagnostic biomarker for liver cancer.
P2860
Q26783895-A707BB95-61C2-4F77-B196-19B52B47546DQ27004276-D68555DC-348B-47FC-AD3B-71FC358C0EC9Q33794350-83C48FAF-98C0-478B-BA93-884BB57FED64Q35793100-F2049E7E-1F36-4D18-B5CE-F3FDC40ED9B9Q35922779-1B9D47F9-9AD8-450E-9870-B8407047F868Q36070099-94010EE9-084B-412A-8640-941B6D0C5977Q36675015-5CB81C14-C762-4DBE-A7EE-2D3FFA0FC28AQ37031712-14AD7CCD-F7F3-47EF-9C39-665E7008F27CQ37046852-DF6E100D-E4BC-4F01-AEB9-0DEE5BB41FAFQ37317462-70998303-5BA4-4356-AFA8-55A8EAC97D19Q37687133-469BC8BC-5604-462F-B125-6375C59E2908Q38450711-BF5A2EB7-F4BC-4294-8CD4-ACC27567D12FQ38637305-F76A6FF4-7750-4526-8890-2DC397138385Q41355749-730A9F1E-C98D-4791-9BEF-3DA5835FAB41Q43470197-A3AF5752-4A30-45D2-A65D-0775170EACB5Q47692343-DBE73C8C-8252-4883-8F54-7665FACD8FE2Q49431252-1DC0316A-EE5F-47B5-BF40-FE709CD84751
P2860
Predictive biomarkers of antiangiogenic therapy for advanced hepatocellular carcinoma: where are we?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Predictive biomarkers of antia ...... lular carcinoma: where are we?
@en
Predictive biomarkers of antia ...... lular carcinoma: where are we?
@nl
type
label
Predictive biomarkers of antia ...... lular carcinoma: where are we?
@en
Predictive biomarkers of antia ...... lular carcinoma: where are we?
@nl
prefLabel
Predictive biomarkers of antia ...... lular carcinoma: where are we?
@en
Predictive biomarkers of antia ...... lular carcinoma: where are we?
@nl
P2093
P2860
P356
P1433
P1476
Predictive biomarkers of antia ...... lular carcinoma: where are we?
@en
P2093
Ann-Lii Cheng
Chih-Hung Hsu
Yu-Yun Shao
P2860
P304
P356
10.1159/000343845
P577
2013-04-01T00:00:00Z